EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

SAFETY AND EFFICACY OF CORNEAL WAVEFRONT GUIDED LASER IN SITU KERATOMILIEUSIS IN MYOPIC ASTIGMATISM

Muhemmed Swadique* and Hassan Sanooj

ABSTRACT

Back Ground: Laser in situ keratomelusis (LASIK) is a widely used refractive surgery technique. Corneal wavefront guided LASIK treatment is a newly evolving method to correct preexisting high order aberrations and also to reduce induction of further aberrations. This study is to assess the efficacy and safety of Corneal wavefront guided LASIK treatment in myopic astigmatism. Methods: This is a prospective study of 30 eyes of 16 patients who underwent Corneal wavefront guided LASIK treatment. The pre operative and post operative one and three month data were collected and analyzed. Results: The post operative mean BSCVA at 1 month was 1.02±0.2 and at 3 month was 1.02±0.18. The change in BSCVA at 1 month was 0.09±0.22 and at 3 month was 0.10 ± 0.22(p <0.001). The change in RMS of 4th order HOA is 0.08±0.01D (p<0.001). and that of the 5th order HOA is 0.02 ±0.04 D (p<0.001). Conclusion: Corneal wavefront guided LASIK treatment is safe and effective in treating patients with myopic astigmatism.

Keywords: Corneal wavefront, higher order aberrations, LASIK.

[Full Text Article] [Download Certificate]